These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23377619)

  • 1. 1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus.
    Nowak N; Skupien J; Cyganek K; Matejko B; Malecki MT
    Diabetologia; 2013 Apr; 56(4):709-13. PubMed ID: 23377619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibling birthweight as a predictor of macrosomia in women with type 1 diabetes.
    Kerssen A; de Valk HW; Visser GH
    Diabetologia; 2005 Sep; 48(9):1743-8. PubMed ID: 16021414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial.
    Murphy HR; Rayman G; Lewis K; Kelly S; Johal B; Duffield K; Fowler D; Campbell PJ; Temple RC
    BMJ; 2008 Sep; 337():a1680. PubMed ID: 18818254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated haemoglobin as an indicator of diabetes control in pregnancy: A 10-year review of the relationship between HbA1c trends and delivery outcome in type I and type II diabetes.
    Finnegan C; Smyth S; Smith O; Dicker P; Breathnach FM
    Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():36-40. PubMed ID: 36529065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different intensities of glycaemic control for pregnant women with pre-existing diabetes.
    Middleton P; Crowther CA; Simmonds L
    Cochrane Database Syst Rev; 2012 Aug; 8(8):CD008540. PubMed ID: 22895976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study.
    Glinianaia SV; Tennant PW; Bilous RW; Rankin J; Bell R
    Diabetologia; 2012 Dec; 55(12):3193-203. PubMed ID: 23015260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control.
    Cyganek K; Skupien J; Katra B; Hebda-Szydlo A; Janas I; Trznadel-Morawska I; Witek P; Kozek E; Malecki MT
    Endocrine; 2017 Feb; 55(2):447-455. PubMed ID: 27726091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need for less tight glucose control in early pregnancy after embryogenesis due to high risk of maternal hypoglycaemia in women with pre-existing diabetes can be compensated by good control in late pregnancy.
    Hauffe F; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M; Schaefer-Graf UM
    Diabet Med; 2020 Sep; 37(9):1490-1498. PubMed ID: 32583455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands.
    Evers IM; de Valk HW; Mol BW; ter Braak EW; Visser GH
    Diabetologia; 2002 Nov; 45(11):1484-9. PubMed ID: 12436330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial.
    Voormolen DN; DeVries JH; Sanson RME; Heringa MP; de Valk HW; Kok M; van Loon AJ; Hoogenberg K; Bekedam DJ; Brouwer TCB; Porath M; Erdtsieck RJ; NijBijvank B; Kip H; van der Heijden OWH; Elving LD; Hermsen BB; Potter van Loon BJ; Rijnders RJP; Jansen HJ; Langenveld J; Akerboom BMC; Kiewiet RM; Naaktgeboren CA; Mol BWJ; Franx A; Evers IM
    Diabetes Obes Metab; 2018 Aug; 20(8):1894-1902. PubMed ID: 29603547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: An interim analysis from a longitudinal mother-child cohort study.
    Gomes D; von Kries R; Delius M; Mansmann U; Nast M; Stubert M; Langhammer L; Haas NA; Netz H; Obermeier V; Kuhle S; Holdt LM; Teupser D; Hasbargen U; Roscher AA; Ensenauer R
    PLoS Med; 2018 Oct; 15(10):e1002681. PubMed ID: 30372451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA1c and Gestational Weight Gain Are Factors that Influence Neonatal Outcome in Mothers with Gestational Diabetes.
    Barquiel B; Herranz L; Hillman N; Burgos MÁ; Grande C; Tukia KM; Bartha JL; Pallardo LF
    J Womens Health (Larchmt); 2016 Jun; 25(6):579-85. PubMed ID: 26918922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989-2008.
    Klemetti M; Nuutila M; Tikkanen M; Kari MA; Hiilesmaa V; Teramo K
    Diabetologia; 2012 Sep; 55(9):2327-34. PubMed ID: 22752076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring, Glycemic Variability, and Excessive Fetal Growth in Pregnancies Complicated by Type 1 Diabetes.
    Mulla BM; Noor N; James-Todd T; Isganaitis E; Takoudes TC; Curran A; Warren CE; O'Brien KE; Brown FM
    Diabetes Technol Ther; 2018 Jun; 20(6):413-419. PubMed ID: 29901410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The duration of intrapartum maternal hyperglycaemia predicts neonatal hypoglycaemia in women with pre-existing diabetes.
    Joshi T; Oldmeadow C; Attia J; Wynne K
    Diabet Med; 2017 May; 34(5):725-731. PubMed ID: 28199038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS
    Cochrane Database Syst Rev; 2014 Apr; (4):CD009613. PubMed ID: 24782359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.
    Kim MJ; Jung HS; Hwang-Bo Y; Cho SW; Jang HC; Kim SY; Park KS
    Acta Diabetol; 2013 Aug; 50(4):505-10. PubMed ID: 21688018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal glycaemic control and risk of neonatal hypoglycaemia in Type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial.
    Yamamoto JM; Corcoy R; Donovan LE; Stewart ZA; Tomlinson G; Beardsall K; Feig DS; Murphy HR;
    Diabet Med; 2019 Aug; 36(8):1046-1053. PubMed ID: 31107983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.